HABA LABORATORIES,INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,015 JPY | -0.20% |
|
+0.05% | -7.19% |
| 2023 | HABA Laboratories,Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
| 2021 | HABA Laboratories,Inc.(JASDAQ:4925) dropped from S&P Global BMI Index | CI |
| Sales 2022 | 12.91B 81.58M 6.51B | Sales 2023 | 12.04B 76.08M 6.07B | Capitalization | 8.81B 55.69M 4.44B |
|---|---|---|---|---|---|
| Net income 2022 | -269M -1.7M -136M | Net income 2023 | -707M -4.47M -357M | EV / Sales 2022 | 0.39 x |
| Net cash position 2022 | 3.09B 19.55M 1.56B | Net cash position 2023 | 2.78B 17.6M 1.4B | EV / Sales 2023 | 0.5 x |
| P/E ratio 2022 |
-30.4
x | P/E ratio 2023 |
-12.5
x | Employees | 654 |
| Yield 2022 |
1.85% | Yield 2023 |
1.72% | Free-Float | 56.05% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.20% | ||
| 1 week | +0.05% | ||
| Current month | -2.99% | ||
| 1 month | -2.99% | ||
| 3 months | -6.71% | ||
| 6 months | -12.88% | ||
| Current year | -7.19% |
1 week
2 012.00
2 024.00
1 month
2 011.002 077.00
Current year
2 011.002 247.00
1 year
2 011.002 500.00
3 years
2 011.004 625.00
5 years
2 011.009 390.00
10 years
2 011.0012 900.00
| Managers | Title | Age | Since |
|---|---|---|---|
Issei Miyazaki
CEO | Chief Executive Officer | 61 | 30/09/13 |
Noriko Koyanagi
CHM | Chairman | 78 | 31/05/15 |
| Chief Tech/Sci/R&D Officer | 59 | 31/05/20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Tsunekazu Umeda
BRD | Director/Board Member | 78 | 31/05/00 |
Noriko Koyanagi
CHM | Chairman | 78 | 31/05/15 |
Issei Miyazaki
CEO | Chief Executive Officer | 61 | 30/09/13 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 2,015 | -0.20% | 1,200 |
| 25/04/24 | 2,019 | +0.15% | 1,800 |
| 24/04/24 | 2,016 | -0.20% | 2,500 |
| 23/04/24 | 2,020 | 0.00% | 1,300 |
| 22/04/24 | 2,020 | +0.30% | 2,200 |
Delayed Quote Japan Exchange, April 26, 2024 at 07:00 am
More quotes
HABA LABORATORIES, INC. is principally engaged in the manufacture and sale of cosmetics and dietary supplements. The Company's main business consists of the research, development, manufacture and distribution of women's and men's cosmetics. The Company offers its products by wholesale distribution to department stores and through mail order services to general customers. It also handles wholesale distribution to retailers and wholesalers, as well as the sale of products at its own retail stores.
Sector
Personal Products
Calendar
09/05/2024
- Q4 2023 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -7.19% | 48.41M | |
| +10.09% | 18.86B | |
| 0.00% | 17.37B | |
| -1.32% | 10.65B | |
| -7.73% | 10.26B | |
| +3.86% | 6.72B | |
| +9.76% | 5.94B | |
| -0.06% | 4.55B | |
| -16.98% | 3.83B | |
| -6.25% | 3.48B |
- Stock Market
- Equities
- 4925 Stock
